Goldman Sachs’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.5M | Buy |
225,992
+48,728
| +27% | +$2.05M | ﹤0.01% | 2306 |
|
|
2025
Q1 | $6.71M | Sell |
177,264
-102,131
| -37% | -$3.87M | ﹤0.01% | 2525 |
|
|
2024
Q4 | $21.5M | Sell |
279,395
-225
| -0.1% | -$17.3K | ﹤0.01% | 1728 |
|
|
2024
Q3 | $16.1M | Buy |
279,620
+148,623
| +113% | +$8.55M | ﹤0.01% | 1887 |
|
|
2024
Q2 | $5.42M | Buy |
130,997
+32,362
| +33% | +$1.34M | ﹤0.01% | 2551 |
|
|
2024
Q1 | $6.02M | Buy |
+98,635
| New | +$6.02M | ﹤0.01% | 2428 |
|
|
2023
Q4 | – | Sell |
-6,174
| Closed | -$158K | – | 4881 |
|
|
2023
Q3 | $158K | Sell |
6,174
-4,061
| -40% | -$104K | ﹤0.01% | 4307 |
|
|
2023
Q2 | $177K | Sell |
10,235
-40,477
| -80% | -$698K | ﹤0.01% | 4436 |
|
|
2023
Q1 | $615K | Buy |
50,712
+2,749
| +6% | +$33.4K | ﹤0.01% | 3970 |
|
|
2022
Q4 | $1.71M | Sell |
47,963
-26,877
| -36% | -$960K | ﹤0.01% | 3377 |
|
|
2022
Q3 | $2.55M | Buy |
74,840
+35,127
| +88% | +$1.2M | ﹤0.01% | 3181 |
|
|
2022
Q2 | $1.46M | Buy |
39,713
+30,410
| +327% | +$1.12M | ﹤0.01% | 3681 |
|
|
2022
Q1 | $1.43M | Buy |
9,303
+4,244
| +84% | +$650K | ﹤0.01% | 3848 |
|
|
2021
Q4 | $1.5M | Sell |
5,059
-2,200
| -30% | -$650K | ﹤0.01% | 3716 |
|
|
2021
Q3 | $2.01M | Buy |
7,259
+1,500
| +26% | +$416K | ﹤0.01% | 3478 |
|
|
2021
Q2 | $1.58M | Sell |
5,759
-886
| -13% | -$243K | ﹤0.01% | 3691 |
|
|
2021
Q1 | $3.27M | Buy |
6,645
+2,263
| +52% | +$1.11M | ﹤0.01% | 2978 |
|
|
2020
Q4 | $3.62M | Buy |
+4,382
| New | +$3.62M | ﹤0.01% | 2677 |
|